Causaly

The pace of biomedical research has limited innovation. Leading R&D enterprises rely on Bio Graph for: Biomarker discovery, Preclinical safety, Target identification and prioritization..

Understand the entirety of internal and external biomedical information in the time it takes to type a question.

Causaly consolidates internal and external data to create a unified source of truth for R&D teams.

Causaly’s biomedical knowledge graph delivers high-precision data for life sciences.

Discover the latest reports, data sheets, articles, infographics, and videos on biomedical R&D and AI.

Causaly shares case studies demonstrating how it has helped customers.

Causaly provides downloadable content.

Helping R&D teams move from raw internal data to cited, defensible scientific decisions in a single governed workflow —setting a new standard for speed, rigor, and provenance in drug discovery and development

What compresses is the knowledge work, the analytical layer that sits on a program’s critical path: building a baseline of what’s known, drafting protocols, reviewing safety, selecting candidates.

Partnership allows Causaly AI agents to access and read full-text of Sage journal articles and deliver the most relevant insights directly within the Causaly platform, helping mutual customers unlock deeper evidence from their existing institutional licenses

Collaboration embeds evidence-grounded agentic AI into scientific workflows across Syneos Health,accelerating research while strengthening scientific rigor, consistency, and sponsor value

Let’s work together to redefine the boundaries of human discovery.

Only Causaly combines advanced agentic AI, precision knowledge graphs, and workflow automation to accelerate R&D productivity and decision-making at scale.

Causaly’s Privacy policy is available for review.

Causaly integrates its evidence-based research tools into Microsoft 365 Copilot, enabling enterprise scientists and knowledge workers to access scientifically grounded insights directly within the platform. The integration aims to assist users in converting research evidence into actionable decision-making intelligence.

Sep 2026PR NewswireNews article

Causaly introduces an AI-driven tool called Pipeline Graph, designed to combine competitive intelligence with preclinical research on one platform. The application aims to streamline drug target identification and improve commercial outcomes for pharmaceutical research. The unified system integrates data to provide researchers with actionable insights.

Jun 2025PR NewswireNews article

Causaly raises £45.8m in Series B funding to advance its AI-driven biotech research platform. The London-based company leverages artificial intelligence to analyze complex biological data for drug discovery and medical insights. This funding round highlights growing investor confidence in AI applications within life sciences.

Jul 2023UKTNNews article

Causaly secures $60 million in Series B funding to advance its AI-driven platform for analyzing biomedical datasets and literature. The round is led by ICONIQ Growth, supporting further development of its technology for research applications.

Jul 2023MobiHealthNewsNews article